A judge has granted preliminary approval for the University of North Carolina (UNC) to settle a lawsuit over allegations that a no-hire agreement between the university and Duke University violated antitrust laws.
The lawsuit was filed in 2015 on behalf of Danielle Seaman, who was an assistant professor of radiology at Duke, who says she was passed over for a similar job at UNC because of an agreement between medical schools at the two institutions not to hire each other’s employees for positions of the same rank.
The law firm representing Seaman announced the partial settlement news this morning. Duke has not settled in the case. Duke has denied the allegations and The Herald-Sun reports that Nancy Andrews, the former dean of Duke’s medical school, and other faculty have filed statements in the same vein.
In the lawsuit, Seaman says she had been trying to get a job at Carolina for three years and was told in 2015 that she was a strong candidate but couldn’t be hired because “lateral moves of faculty between Duke and UNC are not permitted.”
In an email included in the lawsuit, UNC’s chief of cardiothoracic imaging says this arrangement had been in place for a few years and suggested it was intended to suppress salaries.
“The ‘guideline’ was generated in response to an attempted recruitment by Duke a couple of years ago of the entire UNC bone marrow transplant team; UNC had to generate a large retention package to keep the team intact,” the email reads.
“Because Duke/DUHS and UNC/UNC Health are the two largest academic medical systems in the state, their no-hire agreement has reduced competition for medical facility faculty and certain staff, thereby suppressing faculty and staff pay,” the lawsuit says.
Full Content: Herald Sun & Business Wire
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Appoints Law Firms to Lead Consumer Antitrust Litigation Against Apple
Dec 22, 2024 by
CPI
Epic Health Systems Seeks Dismissal of Antitrust Suit Filed by Particle Health
Dec 22, 2024 by
CPI
Qualcomm Secures Partial Victory in Licensing Dispute with Arm, Jury Splits on Key Issues
Dec 22, 2024 by
CPI
Google Proposes Revised Revenue-Sharing Limits Amid Antitrust Battle
Dec 22, 2024 by
CPI
Japan’s Antitrust Authority Expected to Sanction Google Over Monopoly Practices
Dec 22, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand